Marta Hlawaty Selected Research

moexipril (Perdix)

1/2005	Regression of left ventricular hypertrophy with moexipril, an angiotensin-converting enzyme inhibitor, in hypertensive patients.
2/2002	Reversal of left ventricular hypertrophy with the ACE inhibitor moexipril in patients with essential hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marta Hlawaty Research Topics

Disease

5	Atrial Heart Septal Defects (Atrial Septal Defect) 09/2004 - 01/2004
4	Aortic Valve Stenosis (Aortic Stenosis) 12/2011 - 08/2008
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2020 - 01/2017
3	Fibrosis (Cirrhosis) 01/2020 - 01/2017
2	Neoplasms (Cancer) 06/2017 - 01/2017
2	Pain (Aches) 03/2006 - 09/2004
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2005 - 02/2002
2	Essential Hypertension 01/2005 - 02/2002
1	Endocarditis 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Thrombosis (Thrombus) 01/2012
1	Stroke (Strokes) 08/2011
1	Myocardial Infarction 08/2011
1	Pathologic Constriction (Stenosis) 12/2010
1	Atherosclerotic Plaque (Atheroma) 06/2009
1	Coronary Artery Disease (Coronary Atherosclerosis) 08/2008
1	Carotid Stenosis (Carotid Artery Stenosis) 08/2008
1	Angina Pectoris 01/2004

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
3	procollagen type I carboxy terminal peptide (PICP)IBA 01/2020 - 01/2017
3	Connective Tissue Growth FactorIBA 01/2020 - 01/2017
3	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2020 - 01/2017
3	Thrombin FDA Link 12/2011 - 06/2009
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 01/2017
2	Collagen Type I (Type I Collagen)IBA 01/2020 - 01/2017
2	Peptides (Polypeptides)IBA 06/2017 - 01/2017
2	CollagenIBA 06/2017 - 01/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2017 - 01/2017
2	Phosphotransferases (Kinase)IBA 03/2006 - 09/2004
2	Creatine Kinase (Creatine Phosphokinase)IBA 03/2006 - 09/2004
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2005 - 02/2002
2	moexipril (Perdix)FDA LinkGeneric 01/2005 - 02/2002
1	SodiumIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Galectin 3 (LGALS3)IBA 01/2020
1	OximesIBA 01/2020
1	SymportersIBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 06/2017
1	von Willebrand FactorIBA 12/2011
1	FibrinIBA 02/2011
1	Thromboplastin (Tissue Factor)IBA 10/2009
1	amsonic acid (DAS)IBA 08/2008
1	Dobutamine FDA LinkGeneric 01/2004

Therapy/Procedure

5	Septal Occluder Device 09/2004 - 01/2004
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 08/2011 - 12/2010
1	Stents 01/2012
1	Carotid Endarterectomy 08/2011
1	Lasers (Laser) 01/2004